Inventor
JEFFREY L. CLELAND
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations41%
A61KPreparations for medical, dental or toiletry purposes35%
C07DHeterocyclic compounds6%
C07KPeptides6%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds6%
C12NMicroorganisms or enzymes6%
PatentTitleYear
12,121,585Dendrimer compositions and methods for drug delivery to the eye202412,071,456Extended recombinant polypeptides and compositions comprising same202411,931,418Methods of treating severe inflammation202411,564,890Aggregating microparticles for medical therapy202311,548,861Drugs and compositions for the treatment of ocular disorders202311,331,276Aggregating microparticles for medical therapy202211,160,870Extended release microparticles and suspensions thereof for medical therapy2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to GRAYBUG VISION INC (4)· patent assignee history
2021–2024Based in US· patent location history
2024Patents assigned to ASHVATTHA THERAPEUTICS INC (2)· patent assignee history
2024Patents assigned to AMUNIX PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GRAYBUG VISION INC | 4 | 2021–2023 |
| ASHVATTHA THERAPEUTICS INC | 2 | 2024 |
| AMUNIX PHARMACEUTICALS INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2024 |